Clinical trial
The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer
NCT00206609 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00206609 |
|---|---|
| Title | The Role of Oxygen in the Management of Dyspnoea in Advanced Cancer |
| Official title | A Randomised, Double-Blind Cross-Over Trial of the Effect of Oxygen on Dyspnoea in Patients With Advanced Cancer |
| Lead sponsor | Bayside Health, Other |
| Collaborators | Peter MacCallum Cancer Centre, Australia Bethlehem Griffiths Research Foundation Australian and New Zealand Society of Palliative Medicine |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Procedure |
| Interventions | Oxygen and air administration |
| Enrollment | 50 |
| Start date | Nov 1, 2000 |
| Completion | Mar 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: